Shanghai Rightongene Biotechnology Co. Ltd. Class ASSE: 688217

Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2025 Annual Report

· Issued by Shanghai Rightongene Biotechnology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Shanghai Rightongene Biotechnology Co. Ltd. Class A

All Shanghai Rightongene Biotechnology Co. Ltd. Class A news releases